These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5121380)

  • 1. Nature of the gastric hypersecretion associated with intestinal exclusion.
    Villar H; Abbott AG; Williams RJ; Rosen H; Orloff MJ
    Surg Forum; 1971; 22():299-300. PubMed ID: 5121380
    [No Abstract]   [Full Text] [Related]  

  • 2. Site of origin of the hormone responsible for gastric hypersecretion associated with portacaval shunt.
    Orloff MJ; Villar-Valdes H; Abbott AG; Williams RJ; Rosen H
    Surgery; 1970 Jul; 68(1):202-7; discussion 207-8. PubMed ID: 10483470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous origin of the humoral agent responsible for gastric hypersecretion associated with portacaval shunt.
    Villar-Valdes H; Thompson AG; Rosen H; Chandler JG; Orloff MJ
    Surg Forum; 1969; 20():360-2. PubMed ID: 5383087
    [No Abstract]   [Full Text] [Related]  

  • 4. Some observations on the cause of the gastric hypersecretion following portacaval shunt.
    McPhedran NT; Bett HD; Stone RM; Goldberg M
    Bull Soc Int Chir; 1968; 27(4):286-90. PubMed ID: 5714998
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum gastrin, gastrointestinal tissue gastrin, gastric hypersecretion after portacaval shunt in rats.
    Reichle FA; Reeder DD; Reichle RM; Thompson JC
    Surg Forum; 1974; 25(0):418-20. PubMed ID: 4439213
    [No Abstract]   [Full Text] [Related]  

  • 6. Site of origin of the hormone responsible for gastric hypersecretion in humans with portacaval shunts.
    Abbott AG; Rosen H; Orloff MJ
    Surg Forum; 1970; 21():340-3. PubMed ID: 5514758
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extragastric factors of hypersecretion].
    Ramírez Mata M
    Rev Gastroenterol Mex; 1976; 41(2):55-7. PubMed ID: 1029865
    [No Abstract]   [Full Text] [Related]  

  • 8. Humoral mediation of the intestinal phase of gastric secretion and of acid hypersecretion associated with portacaval suhunts.
    Orloff MJ; Villar-Valdes H; Rosen H; Thompson AG; Chandler JG
    Surgery; 1969 Jul; 66(1):118-30. PubMed ID: 5788367
    [No Abstract]   [Full Text] [Related]  

  • 9. The magnitude of the intestinal phase of gastric-acid secretion.
    Buxton BF; Wasunna AE; Bedi BS; Gillespie IE
    Br J Surg; 1970 Nov; 57(11):857-8. PubMed ID: 5482298
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiopathology of gastric hypersecretion after portacaval anastomosis].
    Ectors P; Limbosch JM; De Graef J
    Acta Gastroenterol Belg; 1971 Feb; 34(2):232-40. PubMed ID: 5565414
    [No Abstract]   [Full Text] [Related]  

  • 11. Nature of the humoral agent responsible for portacaval shunt-related gastric hypersecretion in man.
    Orloff MJ; Abbott AG; Rosen H
    Am J Surg; 1970 Aug; 120(2):237-43. PubMed ID: 5456411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the study of acid hypersecretion of the stomach after portacaval transposition in the dog].
    Hubens A
    Acta Gastroenterol Belg; 1966 Nov; 29(11):1008-37 contd. PubMed ID: 5990092
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum gastrin-like activity following portacaval shunt in dogs.
    Wilken BJ; Hunt DG; Hardy JD
    Br J Surg; 1969 Sep; 56(9):695. PubMed ID: 5808390
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of portacaval transposition on the early intestinal phase of gastric secretion.
    SOUTHWELL JM; BAKER DM; WINNER RB; CLARKE JS
    Surg Forum; 1961; 12():278-9. PubMed ID: 13915468
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological changes in the stomach in portocaval anastomosis in dogs].
    Rudenskaia MV
    Eksp Khir Anesteziol; 1967; 12(2):34-8. PubMed ID: 5618922
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evolutive aspects of gastric hypersecretion in experimental choledocho-jejunal shunt].
    Campodonico A; Dettori G; Satta U
    Boll Soc Ital Biol Sper; 1969 Sep; 45(18):1223-4. PubMed ID: 5384460
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of portacaval shunting on postprandial serum gastrin levels in dogs.
    Clendinnen BG; Reeder DD; Jackson BM; Miller JH; Thompson JC
    Surg Forum; 1970; 21():339-40. PubMed ID: 5514757
    [No Abstract]   [Full Text] [Related]  

  • 18. Steatorrhea after massive bowel resection: effects of surgical reduction of gastric acid secretion.
    Burrington JD; Hamilton JR
    Surg Forum; 1969; 20():341-3. PubMed ID: 5383081
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the small intestine in gastric hypersecretion following portacaval shunt.
    CASTANEDA A; GRIFFEN WO; NICOLOFF DM; STONE NH; LEONARD AS; WANGENSTEEN OH
    J Surg Res; 1961 Sep; 1():221-4. PubMed ID: 13691375
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the site of origin of the agent causing hypersecretion in dogs with portacaval shunt.
    CLARKE JS; McKISSOCK PK; CRUZE K
    Surgery; 1959 Jul; 46(1):48-55. PubMed ID: 13668814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.